These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 10371413)

  • 1. Cytokine regulation of hepatic stellate cells in liver fibrosis.
    Tsukamoto H
    Alcohol Clin Exp Res; 1999 May; 23(5):911-6. PubMed ID: 10371413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stellate cell activation in alcoholic fibrosis--an overview.
    Friedman SL
    Alcohol Clin Exp Res; 1999 May; 23(5):904-10. PubMed ID: 10371412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine receptors and signaling in hepatic stellate cells.
    Pinzani M; Marra F
    Semin Liver Dis; 2001 Aug; 21(3):397-416. PubMed ID: 11586468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of hepatic stellate cell migration during liver fibrosis].
    Yang CQ; Yang L; Yang WZ; Zhang Z; Zhang H; Chang YZ; Yuan M; Chen XM
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):119-22. PubMed ID: 18353220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis.
    Gressner AM
    Kidney Int Suppl; 1996 May; 54():S39-45. PubMed ID: 8731193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern.
    Ruehl M; Erben U; Kim K; Freise C; Dagdelen T; Eisele S; Trowitzsch-Kienast W; Zeitz M; Jia J; Stickel F; Somasundaram R
    J Nutr Biochem; 2009 Aug; 20(8):597-606. PubMed ID: 18824344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Migration of hepatic stellate cells in fibrotic microenvironment of diseased liver model.
    Chang YZ; Yang L; Yang CQ
    Hepatobiliary Pancreat Dis Int; 2008 Aug; 7(4):401-5. PubMed ID: 18693176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic fibrogenesis: the puzzle of interacting cells, fibrogenic cytokines, regulatory loops, and extracellular matrix molecules.
    Gressner AM
    Z Gastroenterol; 1992 Mar; 30 Suppl 1():5-16. PubMed ID: 1449018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic stellate cells and the reversal of fibrosis.
    Kisseleva T; Brenner DA
    J Gastroenterol Hepatol; 2006 Oct; 21 Suppl 3():S84-7. PubMed ID: 16958681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells.
    Wobser H; Dorn C; Weiss TS; Amann T; Bollheimer C; Büttner R; Schölmerich J; Hellerbrand C
    Cell Res; 2009 Aug; 19(8):996-1005. PubMed ID: 19546889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular communications and cell-matrix interactions in the pathogenesis of fibroproliferative diseases: liver fibrosis as a paradigm.
    Gressner AM; Bachem MG
    Ann Biol Clin (Paris); 1994; 52(3):205-26. PubMed ID: 7998677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic stellate cell behavior during resolution of liver injury.
    Iredale JP
    Semin Liver Dis; 2001 Aug; 21(3):427-36. PubMed ID: 11586470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells.
    Migita K; Maeda Y; Abiru S; Nakamura M; Komori A; Yokoyama T; Takii Y; Mori T; Yatsuhashi H; Eguchi K; Ishibashi H
    Life Sci; 2006 Apr; 78(21):2510-5. PubMed ID: 16303143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects and regulation of osteopontin in rat hepatic stellate cells.
    Lee SH; Seo GS; Park YN; Yoo TM; Sohn DH
    Biochem Pharmacol; 2004 Dec; 68(12):2367-78. PubMed ID: 15548383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines and fibrogenesis.
    Friedman SL
    Semin Liver Dis; 1999; 19(2):129-40. PubMed ID: 10422196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fibrosis, stellate cells, and portal hypertension.
    Rockey DC
    Clin Liver Dis; 2006 Aug; 10(3):459-79, vii-viii. PubMed ID: 17162223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autocrine release of TGF-beta by portal fibroblasts regulates cell growth.
    Wells RG; Kruglov E; Dranoff JA
    FEBS Lett; 2004 Feb; 559(1-3):107-10. PubMed ID: 14960316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiles during hepatic stellate cell activation in culture and in vivo.
    De Minicis S; Seki E; Uchinami H; Kluwe J; Zhang Y; Brenner DA; Schwabe RF
    Gastroenterology; 2007 May; 132(5):1937-46. PubMed ID: 17484886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of TGF-beta dependent growth control during HSC transdifferentiation.
    Purps O; Lahme B; Gressner AM; Meindl-Beinker NM; Dooley S
    Biochem Biophys Res Commun; 2007 Feb; 353(3):841-7. PubMed ID: 17204247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
    Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
    J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.